For example, in NSCLC, erlotinib and gefitinib can induce a high level of autophagy as a drug resistance and cytoprotective mechanism that was accompanied by the suppression of the PI3K/AKT/mTOR signaling cascade. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.